Clinical trial
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or…
NCT00075595 · GERCOR - Multidisciplinary Oncology Cooperative Group, Other · Unknown status
Key facts
| NCT number | NCT00075595 |
|---|---|
| Title | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer |
| Official title | Phase II Study of 5FU/Folinic Acid and Irinotecan as Second or Third Line Treatment in Patients With Metastatic, Unresectable, Colorectal Cancer |
| Lead sponsor | GERCOR - Multidisciplinary Oncology Cooperative Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Start date | Jun 1, 2002 |
| First posted | Jan 12, 2004 |
| Last update posted | Jan 6, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: